Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
Leonardo De LucaPaolo CalabròFabio ChirilloCristina RolfoAlberto MenozziPiera CapranzanoMaurizio MenichelliElisa NicoliniCiro MauroCarlo TraniFrancesco VersaciFabrizio TomaiGiuseppe MusumeciCarlo Di MarioMartino PepeSergio BertiCarlo CernettiPlinio CirilloDiego MaffeoGiuseppe TalanasMarco FerliniMarco ContariniValerio LanzilottiMarino ScherilloFrancesco CardaioliSimone MuragliaRoberta RossiniLeonardo Bolognesenull nullPublished in: Clinical cardiology (2022)
The interim results of the ARCANGELO study provide a preliminary confirmation that the use of cangrelor on patients with ACS undergoing PCI is not associated with severe bleedings.